Patents | Published:

PATENTS

Worldwide CRISPR patent landscape shows strong geographical biases

A survey of the CRISPR patent landscape shows the improvement of technology, a diversity of potential sectors of application, and a new geopolitical balance of forces in the field.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Jinek, M. et al. Science 337, 816–821 (2012).

  2. 2.

    Cong, L. et al. Science 339, 819–823 (2013).

  3. 3.

    Mali, P. et al. Science 339, 823–826 (2013).

  4. 4.

    Harrison, C. Nat. Biotechnol. 36, 209 (2018).

  5. 5.

    Lim, D. Pharm. Pat. Anal. 7, 141–145 (2018).

  6. 6.

    Sherkow, S. CRISPR J. 1, 309–311 (2018).

  7. 7.

    Parthasarathy, S. Nature 562, 486–488 (2018).

  8. 8.

    Egelie, K. J., Graff, G. D., Strand, S. P. & Johansen, B. Nat. Biotechnol. 34, 1025–1031 (2016).

  9. 9.

    Smith, J. A., Arshad, Z., Thomas, H., Carr, A. J. & Brindley, D. A. Nat. Biotechnol. 35, 210–214 (2017).

  10. 10.

    Maus, M. V. & Levine, B. L. Oncologist 21, 608–617 (2016).

  11. 11.

    Feng, W. et al. Int. J. Mol. Sci. 16, 6545–6556 (2015).

  12. 12.

    Ferreira, R., David, F. & Nielsen, J. J. Ind. Microbiol. Biotechnol. 45, 467–480 (2018).

  13. 13.

    Ricroch, A. E., Ammann, K. & Kuntz, M. EMBO Rep. 17, 1365–1369 (2016).

  14. 14.

    Bhat, S. A. et al. Vet. World 10, 1361–1366 (2017).

  15. 15.

    Sherkow, J. S. Yale J. Biol. Med. 90, 667–672 (2017a).

  16. 16.

    Sherkow, J. S. J. Law Biosci. 4, 565–576 (2017b).

  17. 17.

    Sherkow, J. S. EMBO Rep. 18, 1047–1051 (2017c).

  18. 18.

    Callaway, E. Nature 560, 16 (2018).

  19. 19.

    Rodriguez-Navarro, A. & Narin, F. Sci. Public Policy 45, 14–23 (2018).

  20. 20.

    Kuntz, M. & Berezow, A. Timidity and a hostility to competition have left Europe a scientific wasteland. The Telegraph (5 September 2017).

  21. 21.

    Belda, I., Penas, G., Marquina, D. & Santos, A. Trends Biotechnol. 32, 393–395 (2014).

  22. 22.

    Brinegar, K. et al. Crit. Rev. Biotechnol. 37, 1–12 (2017).

  23. 23.

    De Rassenfosse, G. & Raiteri, E. Technology protectionism and the patent system: strategic technologies in China. SSRN. https://doi.org/10.2139/ssrn.2803379 (2016).

Download references

Acknowledgements

The contributions of U. Del Ghingaro and M. Jamet to early stages of this work are gratefully acknowledged. The authors also thank M. Brites Teixeira for comments and Patent Pulse for allowing us temporary free access to their database.

Author information

Correspondence to Agnès E. Ricroch.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Supplementary Note

Criteria used for patent selection and for further categorization

Supplementary Table 1

CRISPR patent compilation

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1: Geographical repartition and evolution of patent families related to the CRISPR gene editing system.
Fig. 2: Number of patent families related to the CRISPR system per technical category.